DBD
DBD
NYSE · Technology

Diebold Nixdorf Inc

$63.20
-0.29 (-0.46%)
As of Sep 20, 10:04 PM ET ·
Financial Highlights (FY 2026)
Revenue
3.52B
Net Income
87.50M
Gross Margin
26.4%
Profit Margin
2.5%
Rev Growth
+3.2%
D/E Ratio
0.86
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 26.4% 26.4% 62.0% 62.0%
Operating Margin 6.4% 5.7% 23.8% 24.5%
Profit Margin 2.5% 2.4% 21.9% 24.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 3.52B 3.41B 350.37M 397.27M
Gross Profit 928.28M 899.32M 217.38M 246.48M
Operating Income 223.89M 195.21M 83.22M 97.46M
Net Income 87.50M 76.30M 76.72M 98.58M
Gross Margin 26.4% 26.4% 62.0% 62.0%
Operating Margin 6.4% 5.7% 23.8% 24.5%
Profit Margin 2.5% 2.4% 21.9% 24.8%
Rev Growth +3.2% +3.2% +6.5% +14.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 495.61M 495.61M 538.36M 459.72M
Total Equity 577.10M 577.10M 1.05B 1.01B
D/E Ratio 0.86 0.86 0.51 0.46
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 341.78M 314.56M 102.75M 125.92M
Free Cash Flow 87.64M 93.06M